Revisão | Visão geral e de mecanismos da toxicidade cardiovascular com inibidores de BRAF e MEK.

Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review

Comentário no Twitter

New #JACCCardioOnc issue is out!

BRAF/MEK inhibitors are associated w/ adverse CV effects including HTN, LV dysfunction, #VTE, atrial arrhythmias, & QT prolongation. Learn more in this state-of-the-art review: https://t.co/2r9L90DTmL#CardioOnc #CardioTwitter #Hypertension pic.twitter.com/Dz8i0sfBTU

— JACC Journals (@JACCJournals) March 15, 2022